Teva Pharmaceuticals · 21 hours ago
Senior Director Global Pricing, Value & Access (GPS)
Parsippany, NJ
Full-time
Onsite
Director/Executive
$209K/yr - $274K/yr
15+ years expTeva Pharmaceuticals is a leading innovative biopharmaceutical company dedicated to addressing patients’ needs. The Senior Director of Global Pricing, Value & Access will be responsible for supporting global pricing, access, and value strategies to maximize patient access and long-term value for Teva’s neurology and immunology portfolio of medicines.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Define and implement global pricing, access, and value strategies for key innovative medicines
Craft early value narratives and payer messaging to guide evidence generation and support successful reimbursement
Partner with Medical Affairs and Clinical Development to ensure payer-relevant data informs clinical programs and enhances access potential
Lead development of global value dossiers and support HTA submissions for launch assets
Establish pricing corridors, manage international reference pricing, and secure governance approvals
Represent Market Access in asset and brand strategy teams, ensuring integrated access planning
Collaborate with affiliates and engage with external experts, payers, and healthcare stakeholders to communicate product value and shape market access environments
Qualification
Required
Advanced degree (PhD, MBA, MS, MPH, or equivalent) in Business, Economics, Epidemiology, Public Health, or Pharmacy
A minimum of 15 years in the pharmaceutical industry, including a minimum of 5 years in pricing, market access, or HEOR leadership roles
Proven success in global or regional market access, with deep understanding of payer landscapes, HTA processes, and value-based pricing models
Experience in Tier 1 markets (US and EU5) required; specialty or rare disease experience preferred
Strong background in Neurology and/or Immunology highly desirable
Exceptional leadership, analytical thinking, and communication; ability to influence cross-functional teams and senior stakeholders in complex, global settings
Preferred
Experience in Tier 1 markets (US and EU5) required; specialty or rare disease experience preferred
Strong background in Neurology and/or Immunology highly desirable
Benefits
Comprehensive Health Insurance: Medical, Dental, Vision, and Prescription coverage starting on the first day of employment, providing the employee enrolls.
Retirement Savings: 401(k) with employer match, up to 6% and an annual 3.75% Defined Contribution to the 401k plan.
Time Off: Paid Time Off including vacation, sick/safe time, caretaker time and holidays.
Life and Disability Protection: Company paid Life and Disability insurance.
Employee Assistance Program
Employee Stock Purchase Plan
Tuition Assistance
Flexible Spending Accounts
Health Savings Account
Life Style Spending Account
Volunteer Time Off
Paid Parental Leave, if eligible
Family Building Benefits
Virtual Physical Therapy
Accident, Critical Illness and Hospital Indemnity Insurances
Identity Theft Protection
Legal Plan
Voluntary Life Insurance
Long Term Disability and more.
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
10001+ employees
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.51BKey Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
Leadership Team
Dipankar Bhattacharjee
President & CEO: Generics Europe
Richard Francis
President and Chief Executive Officer
Recent News
2026-01-17
2026-01-14
2026-01-14
Company data provided by crunchbase